ASHP Applauds CVS Caremark's Move Away from Tobacco Sales
Published Online: Wednesday, February 5, 2014
2/5/2014--The American Society of Health-System Pharmacists (ASHP) applauds the announcement by CVS Caremark today that the company will cease sales of tobacco products in its pharmacies by October 2014.
ASHP has long advocated that pharmacies refrain from selling tobacco products. In addition to policy passed in 1988, the Society published a Therapeutic Position Statement on the pharmacist’s role in smoking cessation efforts that includes strong opposition to the sale or distribution of tobacco products in all health care settings.
“It is contradictory to the role of pharmacies as health care centers to sell tobacco products,” said ASHP CEO Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP. “Pharmacists can play an important role in helping patients to quit tobacco use, and I hope that other companies will follow CVS’ example.”
Several provisions of the Affordable Care Act intend to improve smoking cessation rates by increasing insurance coverage for effective interventions.
The flavorings used to improve the taste of electronic cigarettes may pose their own respiratory health hazards.
Results of a phase 2 clinical study suggest that the weight-loss drug, lorcaserin hydrochloride, is also an effective smoking cessation aid.